Corrigendum to "The use of Pholasin® as a probe for the determination of plasma total antioxidant capacity" [Clin Biochem 39 (2006) 55-61] (DOI:10.1016/j.clinbiochem.2005.09.011);The use of Pholasin® as a probe for the determination of plasma total antioxidant capacity

Clinical Biochemistry

Volumn 39, Issue 1, 2006, Pages 55-61

  Jaffar, Nourooz Zadeh ^a,b   Dan, Ziegler ^c   Christopher, Sohr ^c   John, Betteridge D ^a,b   Jan, Knight ^d   John, Hothersall ^e  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b MIDDLESEX HOSPITAL   (United Kingdom)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d Knight Scientific Ltd   (United Kingdom)

^e INSTITUTE OF UROLOGY AND NEPHROLOGY   (United Kingdom)

Author keywords

Antioxidant capacity; Chemiluminescence; Diabetes; Oxidative stress; Pholasin

Indexed keywords

PEROXYNITRITE; PHOTOPROTEIN; SUPEROXIDE; ANTIOXIDANT; LUCIFERIN; NITRATE; PEROXYNITRIC ACID; PHOLASIN; REACTIVE OXYGEN METABOLITE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MOLECULAR PROBE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION; OXIDATIVE STRESS; PLASMA; POLYNEUROPATHY; PRIORITY JOURNAL; BLOOD; METABOLISM; MIDDLE AGED; TIME;

ADULT; ANTIOXIDANTS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FIREFLY LUCIFERIN; HUMANS; MIDDLE AGED; MOLECULAR PROBES; NITRATES; REACTIVE OXYGEN SPECIES; TIME FACTORS;

EID: 29344458794     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2007.06.002     Document Type: Erratum

References (23)

1. P.A. Low Oxidative stress: an integrative view. In text book of diabetic neuropathy F.A. Gries N.E. Cameron P.A. Low D. Ziegler 2000 Theime Stuttgart 123 127
2. I.G. Obrosova How does glucose generate oxidative stress in peripheral nerve? Int. Rev. Neurobiol. 50 2002 3 35
3. P.S. van Dam Oxidative stress and diabetic neuropathy: pathophysiological mechanisms and treatment perspectives Diabetes Metab. Res. Rev. 18 2002 176 184
4. R.L. Prior, and G. Cao In vivo total antioxidant capacity: comparison of different analytical methods Free Radical Biol. Med. 1999 1173 1181
5. Knight J, Ganderton M, Hothersall J, Zitouni K, Nourooz-Zadeh J. The ABEL® peroxynitrite antioxidant test with Pholasin® measures the antioxidant capacity of plasma to protect against peroxyl radical attack. In bioluminescence and chemiluminescence: progress and current applications. In: Stanley P, Kricka L, editors. World Scientific Publishing Co., Singapore. p. 257-260.
6. B. Halliwell Antioxidants: the basics-What they are and how to evaluate them Adv. Pharmacol. 38 1997 3 20
7. K. Schlesier, M. Harwat, V. Bohm, and R. Bitsch Assessment of antioxidant activity by using different in vitro methods Free Radical Res. 36 2002 177 187
8. G. Bartosz Total antioxidant capacity Adv. Clin. Chem. 37 2003 219 292
9. K.J. Yeum, R.M. Russell, N.I. Krinsky, and G. Aldini Biomarkers of antioxidant capacity in the hydrophilic and lipophilic compartments of human plasma Arch. Biochem. Biophys. 430 2004 97 103
10. D. Ziegler, C. Sohr, and J. Nourooz-Zadeh Oxidative stress and antioxidant defense in relation to the severity of diabetic polyneuropathy and cardiovascular autonomic neuropathy Diabetes Care 27 2004 2178 2183
11. S.A. Santini, G. Marra, and B. Giardina Defective plasma antioxidant defenses and enhanced susceptibility to lipid peroxidation in uncomplicated IDDM Diabetes 46 1997 1853 1858
12. J. Valabhji, A.J. McColl, W. Richmond, M. Schachter, M.B. Rubens, and R.S. Elkeles Total antioxidant status and coronary artery calcification in type 1 diabetes Diabetes Care 24 2001 1608 1613
13. B. Rocic, M. Vucic, J. Knezevic-Cuca, A. Radica, I. Pavlic-Renar, and V. Profozic Total plasma antioxidants in first-degree relatives of patients with insulin-dependent diabetes Exp. Clin. Endocrinol. Diabetes 105 1997 213 217
14. A. Ceriello, N. Bortolotti, A. Crescentini, E. Motz, S. Lizzio, A. Russo, Z. Ezsol, L. Tonutti, and C. Taboga Antioxidant defences are reduced during the oral glucose tolerance test in normal and non-insulin-dependent diabetic subjects Eur. J. Clin. Invest. 28 1998 329 333
15. E.C. Opara, E. Abdel-Rahman, and S. Soliman Depletion of total antioxidant capacity in type 2 diabetes Metabolism 48 1999 1414 1417
16. F. Aguirre, I. Martin, and D. Grinspon Oxidative damage, plasma antioxidant capacity, and glycemic control in elderly NIDDM patients Free Radical Biol. Med. 24 1998 580 585
17. C. Pieri, R. Testa, M. Marra, A.R. Bonfigli, S. Manfrini, and I. Testa Age-dependent changes of serum oxygen radical scavenger capacity and haemoglobin glycosylation in non-insulin-dependent diabetic patients Gerontology 47 2001 88 92
18. B.N. Ames, R. Cathcart, E. Schwiers, and P. Hochstein Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis Proc. Natl. Acad. Sci. U. S. A. 78 1981 6858 6862
19. M. Whiteman, U. Ketsawatsakul, and B. Halliwell A reassessment of the peroxynitrite scavenging activity of uric acid Ann. N. Y. Acad. Sci. 962 2002 242 259
20. D.D. Wayner, G.W. Burton, K.U. Ingold, L.R. Barclay, and S.J. Locke The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma Biochim. Biophys. Acta 924 1987 408 419
21. S.R. Maxwell, H. Thomason, and D. Sandler Poor glycaemic control is associated with reduced serum free radical scavenging (antioxidant) activity in non-insulin-dependent diabetes mellitus Ann. Clin. Biochem. 34 1997 638 644
22. M. Ryan, L. Grayson, and D.J. Clarke The total antioxidant capacity of human serum measured using enhanced chemiluminescence is almost completely accounted for by urate Ann. Clin. Biochem. 34 1997 688 689
23. J. Vessby, S. Basu, R. Mohsen, C. Berne, and B. Vessby Oxidative stress and antioxidant status in type 1 diabetes mellitus J. Intern. Med. 251 2002 69 76